,上海皓元生物醫藥科技有限公司">
![]() |
ONO-7300243研究進展
|
|||||||||||||||||
[發表評論] [本類其他服務] [本類其他服務商] |
服務商: 上海皓元生物醫藥科技有限公司 | 查看該公司所有服務 >> |
ONO-7300243產品描述:ONO-7300243 is a novel, potent lysophosphatidic acid receptor 1 (LPA1) antagonist with IC50 of 0.16 μM. IC50 & Target: IC50: 0.19-0.13 μM (LPA1)[1] In Vitro: ONO-7300243 shows modest in vitro activity (IC50=0.16 μM). ONO-7300243 exhibits almost identical levels of antagonist activity in vitro[1]. In Vivo: ONO-7300243 shows good efficacy in vivo. The oral dosing of 17a at 30 mg/kg leads to reduced intraurethral pressure in rats. ONO-7300243 shows stronge effects in vivo (88% inhibition at 10 mg/kg i.d., 62% inhibition at 3 mg/kg i.d.) compared with compound 12g. The results reveal that ONO-7300243 shows good membrane permeability and good metabolic stability against rat liver microsomes (MS). ONO-7300243 exhibits good selectivity towards LPAl over LPA2, most likely because low molecular weight and low lipophilicity lead to reduced compound promiscuity and increased selectivity. ONO-7300243 inhibit 公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設有歐洲區子公司和亞洲區總代理,營銷網點遍及全球20多個國家地區。MCE經過多年努力已成為全球生物活性小分子領域的一流供應商, 產品涵蓋癌癥、神經科學、抗感染、表觀遺傳學等20個熱門研究領域,PI3K、MAPK等近千個細分靶點,超過4000個活性小分子化合物現貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時提供從毫克到千克的專業定制合成服務。 MCE 對每批產品都進行嚴格的LCMS和NMR檢驗,其產品已被全球近萬名客戶廣泛使用并發表大量文章、專利; MCE 定期增加各領域熱門抑制劑、激動劑,不斷擴增已有化合物庫,以滿足最新的科研需求; 數千種產品在上海有充足備貨,24-48小時內送達客戶; 大量產品提供免費試用裝; 已為全球多個知名企業、院校構建各種定制型化合物庫。 產品鏈接:www.medchemexpress.cn/ono-7300243.html src="http://img.dxycdn.com/trademd/upload/userfiles/image/2014/08/A1408605159png_small.jpg" alt=""> |